Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates.

Rey-Jurado E, Tudó G, de la Bellacasa JP, Espasa M, González-Martín J.

Int J Antimicrob Agents. 2013 Mar;41(3):278-80. doi: 10.1016/j.ijantimicag.2012.11.011. Epub 2013 Jan 9.

PMID:
23312604
2.

Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.

Rey-Jurado E, Tudó G, Martínez JA, González-Martín J.

Tuberculosis (Edinb). 2012 May;92(3):260-3. doi: 10.1016/j.tube.2012.01.005. Epub 2012 Feb 16.

PMID:
22342247
3.
4.

In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.

Zhang Z, Li T, Qu G, Pang Y, Zhao Y.

Int J Antimicrob Agents. 2015 Jan;45(1):71-5. doi: 10.1016/j.ijantimicag.2014.09.012. Epub 2014 Oct 18.

PMID:
25459737
5.

In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.

López-Gavín A, Tudó G, Vergara A, Hurtado JC, Gonzalez-Martín J.

Int J Antimicrob Agents. 2015 Nov;46(5):582-5. doi: 10.1016/j.ijantimicag.2015.08.004. Epub 2015 Sep 7.

PMID:
26421981
6.

Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model.

Rey-Jurado E, Tudó G, Soy D, González-Martín J.

Int J Antimicrob Agents. 2013 Dec;42(6):524-30. doi: 10.1016/j.ijantimicag.2013.07.014. Epub 2013 Sep 5.

PMID:
24080479
7.

Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.

Caleffi-Ferracioli KR, Maltempe FG, Siqueira VL, Cardoso RF.

Tuberculosis (Edinb). 2013 Nov;93(6):660-3. doi: 10.1016/j.tube.2013.09.001. Epub 2013 Sep 13.

PMID:
24083948
8.
9.

Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.

Gonzalo X, Casali N, Broda A, Pardieu C, Drobniewski F.

Int J Antimicrob Agents. 2015 Apr;45(4):406-12. doi: 10.1016/j.ijantimicag.2014.11.017. Epub 2015 Feb 2.

PMID:
25717028
11.
12.
13.

Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.

Gupta P, Jadaun GP, Das R, Gupta UD, Srivastava K, Chauhan A, Sharma VD, Chauhan DS, Katoch VM.

Indian J Med Res. 2006 Feb;123(2):125-30.

PMID:
16575110
14.

In vitro time-kill curves study of three antituberculous combinations against Mycobacterium tuberculosis clinical isolates.

López-Gavín A, Tudó G, Rey-Jurado E, Vergara A, Hurtado JC, Gonzalez-Martín J.

Int J Antimicrob Agents. 2016 Jan;47(1):97-100. doi: 10.1016/j.ijantimicag.2015.10.016. Epub 2015 Nov 21.

PMID:
26691020
15.

[Evaluation of the mycobacterium efficacy of linezolid in vitro].

Huang HR, Yu X, Jiang GL, Dai GM, Bi ZQ, Ma Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2011 Aug;34(8):575-8. Chinese.

PMID:
22168977
16.

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W.

J Clin Microbiol. 2010 May;48(5):1683-9. doi: 10.1128/JCM.01947-09. Epub 2010 Mar 24.

17.

Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.

Cavalieri SJ, Biehle JR, Sanders WE Jr.

Antimicrob Agents Chemother. 1995 Jul;39(7):1542-5.

20.

Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.

Shi D, Li L, Zhao Y, Jia Q, Li H, Coulter C, Jin Q, Zhu G.

J Antimicrob Chemother. 2011 Oct;66(10):2240-7. doi: 10.1093/jac/dkr284. Epub 2011 Jul 21.

Items per page

Supplemental Content

Write to the Help Desk